Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies. 1982

M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman

The hemodynamic and hormonal responses to acute and chronic captopril therapy and to its temporary withdrawal were studied in seven patients with congestive heart failure. Maximal hemodynamic and hormonal effects were reached with 25 to 50 mg doses of captopril. Since plasma angiotensin II levels were significantly higher 6 1/2 hours than 1 hour after administration of captopril, the drug should be given not less often than three times daily. No evidence of hormonal "escape" during long-term (mean 4 1/2 months) captopril therapy was observed, and initial hemodynamic responses were well maintained. Cessation of captopril administration resulted in abrupt increases in circulating angiotensin II levels, in arterial pressure, and in both pulse rate and plasma norepinephrine, but no decrease in cardiac function in the short-term was detected.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
April 1987, The American journal of cardiology,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
October 1983, Circulation,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
November 1982, American heart journal,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
October 1982, Australian and New Zealand journal of medicine,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
January 1986, The American journal of the medical sciences,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
May 1994, Chinese medical journal,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
August 1983, Journal of the American College of Cardiology,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
January 1982, Progress in cardiovascular diseases,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
January 1985, Indian heart journal,
M G Nicholls, and H Ikram, and E A Espiner, and A H Maslowski, and M S Scandrett, and T Penman
January 1983, Giornale italiano di cardiologia,
Copied contents to your clipboard!